Actively Recruiting
Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
Led by Desmond Tutu HIV Foundation · Updated on 2024-11-01
3642
Participants Needed
2
Research Sites
217 weeks
Total Duration
On this page
Sponsors
D
Desmond Tutu HIV Foundation
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will evaluate the impact of U=U messaging and counseling on gaps in the HIV care cascade for men, including testing uptake and ART initiation (Aim 1), achieving viral suppression and retention in care (Aim 2) in two provinces in South Africa. The U=U message communicates the compelling idea that PLHIV who take ART and have an undetectable viral load (\<200 copies/mL) cannot sexually transmit HIV. Additionally, the investigators will conduct a multi-method evaluation to inform future implementation of U=U messaging interventions (Aim 3).
CONDITIONS
Official Title
Improving HIV Testing, Linkage, and Retention in Care for Men Through U=U Messaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male gender
- Age 15 years or older
- For Aim 1: Present a study-issued invitation card to site receptionist
- Ability to provide informed consent
- For Aim 2: Cis-gender men
- Newly initiating ART or re-initiating ART after at least 6 months lost-to-care
- Live in Buffalo City or Cape Town Metro Health Districts
- Provide written informed consent
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Buffalo City Metro
East London, Eastern Cape, South Africa, 5217
Actively Recruiting
2
Cape Town Metro
Cape Town, Western Cape, South Africa, 7405
Actively Recruiting
Research Team
A
Andrew Medina-Marino, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here